Team Careers Products Medical Affairs News Contact

Team Careers Products Medical Affairs News Contact

Back

Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis

March 2, 2020

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

Team Careers Products Medical Affairs - Report Adverse Events - Report Product Complaints News Contact

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

© 2025 INNOVIVA SPECIALTY THERAPEUTICS | ALL RIGHTS RESERVED